Amgen to Broadcast Its 2025 Second Quarter Financial Results via Webcast
Amgen Reveals Q2 2025 Financial Results
Amgen, a leading biopharmaceutical company, announced its second quarter 2025 financial results on Tuesday, August 5, 2025. The earnings webcast, featuring CEO Robert A. Bradway and senior management, took place at 4:30 PM Eastern Time that day.
The financial results presentation and conference call provided insights into the company’s Q2 performance, including a reported 9% revenue increase to $9.2 billion[3][4].
The webcast and conference call were accessible live and for replay on Amgen's website at www.amgen.com in the Investors section. The webcast replay will be available for at least 90 days following the presentation.
Investors and analysts can find more details about Amgen's financial results in the press release issued by the company, which can be found at https://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2025-second-quarter-financial-results-302518785.html.
For media inquiries, please contact Elissa Snook at 609-251-1407. For investor inquiries, you can reach out to Justin Claeys at 805-313-9775.
It is worth noting that Amgen was named one of the "World's Most Innovative Companies" by Fast Company in 2024, as well as one of "America's Best Large Employers" by Forbes in 2024.
Live audio of the conference call will be broadcast over the internet. The financial results announcement will be made after the close of the U.S. financial markets. The webcast and conference call offer a valuable opportunity for stakeholders to gain a comprehensive understanding of Amgen's financial health and strategic direction.
Cloud-based financial news emphasized Amgen's 9% revenue increase to $9.2 billion in Q2 2025, signifying growth in the company's business, while investing opportunities remain for those who reviewed the webcast and conference call, accessible on Amgen's website until replay ends, offering insights into Amgen's strategic direction and financial health.
